If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2000-2003 Ph.D., Graduate Institute of Medicl Sciences, National Defense Medical Center
  • 1986-1993 M.D., School of Medicine, National Defense Medical Center

Experience

  • Vice Superintendent, Taipei Medical University Shuang Ho Hospital
  • 2017 Director, Department of Obstetrics and Gynecology, School of Medicine, Taipei Medical University
  • 2014 Professor, Graduate Institute of Clinical Medicine, Taipei Medical University
  • 2014 Joint Appointment Professor, Tzu Chi University
  • 2014 Chair, Department of OB/ GYN, Shuang Ho Hospital, Taipei Medical University
  • 2013 Deputy Superintendent, Shuang Ho Hospital, Taipei Medical University
  • 2013.11- Professor, Department of Gynecology and Obstetrics, School of Medicine, Taipei Medical University
  • 2013 Joint Appointment Professor, School of Medicine, National Defense Medical Center
  • 2013 Division Chief, Gynecologic Oncology, Tri-Service General Hospital
  • 2011 Professor, School of Medicine, National Defense Medical Center
  • 2010 Division Chief, Obstetrics, Tri-Service General Hospital
  • 2008 Associate professor, School of Medicine, National Defense Medical Center
  • 2005 Assistant professor, School of Medicine, National Defense Medical Center
  • 2005 Visiting Scholar, Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University
  • 2002 Visiting Scholar, German Cancer Research Center (DKFZ), Heidelberg, Germany

Awards

  • 2016 Who's Who in the World
  • 2015 Award of Poster, Clinical Section , The 20th Taiwan Joint Cancer Conference, Taipei (PI)
  • 2014 Award of Poster, Clinical Section , The 19th Taiwan Joint Cancer Conference, Taipei (PI)
  • 2014 Award of Poster, Basic Section , The 19th Taiwan Joint Cancer Conference, Taipei(PI)
  • 2012 Award of Technology Transfer, National Defense Medical Center, Taipei
  • 2012 Award of Poster, Basic Section, The 17th Taiwan Joint Cancer Conference, Taipei (PI)
  • 2012 Merit Award of ACOS (10th International Conference of the Asian Clinical Oncology Society) Seoul, Korea.
  • 2011 Merit Award of ASGO (2nd Biennial Meeting of the Asian Society of Gynecologic Oncology, Seoul, Korea
  • 2011 Taipei Biotech Awards, Industry-University Collaboration, Award Gold Medal Award, Taipei
  • 2011 Award of Poster, Basic Section , The 16th Taiwan Joint Cancer Conference, Taipei
  • 2011 Award of Research, Taiwan Association of Obstetrics and Gynecology, Chien-Tien Hsu Cancer Research Foundation, Taipei
  • 2010 Award of Academic Research Category , The 7th National Innovation Award
  • 2010 Award of Best Poster, Clinical Section , The 15th Taiwan Joint Cancer Conference, Taipei
  • 2010 Award of Best Conference Paper, 4th Biennial Conference of the Asia Oceania research organization on Genital Infections and Neoplasia (AOGIN), India
  • 2009 National Biotechnology and Medical Care Quality Award, Gold, Institute of Biotechnology and Medical Industry, Taipei
  • 2009 Award of Technology Transfer, National Defense Medical Center, Taipei,
  • 2009 Award of Best Research, Taiwan Association of Obstetrics and Gynecology, Chien-Tien Hsu Cancer Research Foundation, Taipei
  • 2009 Award of Best Poster, Basic Section , The14th Taiwan Joint Cancer Conference, Taipei
  • 2009 Award of Best Poster, Clinical Section , The14th Taiwan Joint Cancer Conference, Taipei
  • 2008 Award of Best Poster, Basic Section , The13th Taiwan Joint Cancer Conference, Taipei
  • 2008 Award of Best Poster, Clinical Section , The13th Taiwan Joint Cancer Conference, Taipei
  • 2008 Award of Best presentation in Basic/Translational Research, The 12th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) conference, Bangkok
  • 2008 Award of Member in Good Standing, International Gynecologic Cancer Society.
  • 2006 Afro-Asian Who’s Who
  • 2005 Asia/Pacific Who’s Who
  • 2004 Award of Best Theses, Graduate Institute of Medical Sciences

Research Interests

  • Stem Cell
  • Cancer Epigenetics & Biomarker
  • Gynecologic Oncology
  • Molecular Epidemiology

URL

Fingerprint Dive into the research topics where Hung-Cheng Lai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 30 Similar Profiles
Methylation Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
DNA Methylation Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Genes Medicine & Life Sciences
Biomarkers Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2020

DNA與RNA甲基化與去甲基化在卵巢癌之研究

Lai, H.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

北醫大的表基因轉譯工作組-轉錄表基因組和CRISPR 研究平台的建立

Lai, H.

1/1/1912/1/19

Project: A - Government Institutiond - Ministry of Education

賴鴻政-107研究計畫績效獎

Lai, H.

8/1/187/31/20

Project: B - Project of TMUh - Other (Funded by TMU)

子宮內膜癌分子篩檢試劑套組開發案(III)

Lai, H.

12/1/185/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

表基因工程作為婦科癌症治療策略之研究(3/3)

Lai, H.

8/1/187/1/19

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 1999 2019

  • 4326 Citations
  • 36 h-Index
  • 123 Article
  • 4 Review article
  • 2 Chapter
  • 1 Conference contribution
2 Citations (Scopus)

E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness

Cheng, F. H. C., Lin, H. Y., Hwang, T. W., Chen, Y. C., Huang, R. L., Chang, C. B., Yang, W., Lin, R. I., Lin, C. W., Chen, G. C. W., Mai, S. Y., Lin, J. M. J., Chuang, Y. M., Chou, J. L., Kuo, L. W., Li, C., Cheng, A. S. L., Lai, H. C., Wu, S. F., Tsai, J. C. & 1 others, Chan, M. W. Y., Jan 1 2019, (Accepted/In press) In : Cancer Science.

Research output: Contribution to journalArticle

Ovarian Neoplasms
RNA
Estrogens
E2F6 Transcription Factor
MicroRNAs
2 Citations (Scopus)

TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions

Su, P. H., Hsu, Y. W., Huang, R. L., Chen, L. Y., Chao, T. K., Liao, C. C., Chen, C. W., Wu, T. I., Mao, S. P., Balch, C. & Lai, H. C., May 28 2019, In : Cancer Letters. 450, p. 53-62 10 p.

Research output: Contribution to journalArticle

Dioxygenases
Epithelial-Mesenchymal Transition
Histones
Gene Silencing
5-Methylcytosine
1 Citation (Scopus)

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

Chen, L. Y., Huang, R. L., Chan, M. W. Y., Yan, P. S., Huang, T. S., Wu, R. C., Suryo Rahmanto, Y., Su, P. H., Weng, Y. C., Chou, J. L., Chao, T. K., Wang, Y. C., Shih, I. M. & Lai, H. C., Jan 1 2019, In : Journal of Pathology.

Research output: Contribution to journalArticle

Casein Kinase II
Carcinoma
Dioxygenases
Precision Medicine
Immunomodulation
Robotics
Hysterectomy
Operative Time
Length of Stay
Adenomyosis

ZNF671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

Mase, S., Shinjo, K., Totani, H., Katsushima, K., Arakawa, A., Takahashi, S., Lai, H. C., Lin, R. I., Chan, M. W. Y., Sugiura-Ogasawara, M. & Kondo, Y., Mar 1 2019, In : Cancer Science. 110, 3, p. 1105-1116 12 p.

Research output: Contribution to journalArticle

Open Access
DNA Methylation
Ovarian Neoplasms
Recurrence
Platinum
Atlases